Hardy Reed’s Amgen AMGN Stock Holding History

Hardy Reed’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$492K	Buy	1,167 +38	+3%	+$15.1K	0.03%	156
2026 Q2	$409K	Buy	1,129 +448	+66%	+$153K	0.03%	175
2026 Q1	$240K	Buy	681 +30	+5%	+$10.7K	0.02%	220
2025 Q4	$213K	Buy	+651	New	+$207K	0.02%	228

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Hardy Reed's AMGN Position: Q3 2026 in Review

Hardy Reed increased its Amgen (AMGN) stake by 3.4% in Q3 2026, buying an estimated $15.1K and bringing the position to 1,167 shares worth $492K. The position accounts for 0.03% of the portfolio, ranked #156.

Hardy Reed first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Hardy Reed held 1,167 shares of Amgen worth $492K as of Q3 2026.
Hardy Reed bought 38 Amgen shares in Q3 2026, an estimated $15.1K.
Amgen made up 0.03% of Hardy Reed's portfolio in Q3 2026, its #156 holding.
Hardy Reed first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.